Matt Abernethy's Net Worth
Matt Abernethy's net worth is estimated to be at least $9,081,038.77 as of 05/20/2024. CoreStreet's estimation of Matt Abernethy's net worth is based on their sale of stock and current holding of stock.
Matt Abernethy is CFO at Neurocrine Biosciences Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,000 units of NBIX stock on 05/15/2024. Their biggest sale was on 02/07/2023 when they sold 26,328 units of Neurocrine Biosciences Inc stock for $2,695,987.20. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $9,081,038.77
Most recent insider trade:
- May 15, 2024
Matt Abernethy's Insider Trading History
| Neurocrine Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 15, 2024 | CFO | 15,000 | $140.24 | Sell | $2,103,600.00 |
Feb. 13, 2024 | CFO | 1,352 | $132.85 | Sell | $179,613.20 |
Feb. 8, 2024 | CFO | 980 | $134.21 | Sell | $131,525.80 |
Feb. 6, 2024 | CFO | 1,280 | $142.19 | Sell | $182,003.20 |
Jan. 31, 2024 | CFO | 1,283 | $140.72 | Sell | $180,543.76 |
Aug. 21, 2023 | CFO | 2,132 | $107.39 | Sell | $228,955.48 |
Feb. 7, 2023 | CFO | 26,328 | $102.40 | Sell | $2,695,987.20 |
Jan. 31, 2023 | CFO | 1,283 | $109.98 | Sell | $141,104.34 |
Feb. 7, 2022 | CFO | 3,310 | $80.79 | Sell | $267,414.90 |
Dec. 1, 2021 | CFO | 1,645 | $82.59 | Sell | $135,860.55 |
Feb. 8, 2021 | CFO | 2,910 | $116.82 | Sell | $339,946.20 |
Dec. 1, 2020 | CFO | 1,645 | $94.66 | Sell | $155,715.70 |
May 7, 2020 | CFO | 15,000 | $110.21 | Sell | $1,653,150.00 |
April 28, 2020 | CFO | 1,741 | $102.49 | Sell | $178,435.09 |
Feb. 7, 2020 | CFO | 2,030 | $103.35 | Sell | $209,800.50 |
Dec. 2, 2019 | CFO | 1,645 | $116.33 | Sell | $191,362.85 |
Dec. 3, 2018 | CFO | 1,178 | $90.00 | Sell | $106,020.00 |